Stock Surges 34%: Medical Company Presents This Major Announcement

ImmunityBio's N-803 Shows Promise in Bladder Cancer Treatment: A Deep Dive into the Recent Stock Surge.

Disclaimer: This post may include affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

On Tuesday, ImmunityBio, Inc.'s (NASDAQ: $IBRX) stock surged 34% to close at $1.93. This spike can be attributed to the company's announcement of the resubmission of its Biological License Application (BLA)…